McKechnie William Edward, a director at Lexaria Bioscience Corp. ($LEXX), made one open market purchase of shares in the last year, totaling $4,532. His most recent buy occurred on July 29, 2025. Among nearly 5,000 insiders tracked for purchases, his amount ranks 4,620th, well below the average of $1.5 million across about 3.3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 29, 2025 | Lexaria Bioscience Corp. | $LEXX | McKechnie William Edward | Director | P | common shares | 5000 | $0.91 | 31,382.0000 | 0 | 18.95% | 0.00% |
| May 15, 2025 | Lexaria Bioscience Corp. | $LEXX | McKechnie William Edward | Director | A | Stock Options | 11000 | $0.00 | 248,200.0000 | 0 | 4.64% | 0.00% |
| July 26, 2024 | Lexaria Bioscience Corp. | $LEXX | McKechnie William Edward | Director | A | Stock Options | 12000 | $0.00 | 185,200.0000 | 0 | 6.93% | 0.00% |
| April 26, 2024 | Lexaria Bioscience Corp. | $LEXX | McKechnie William Edward | Director | A | Stock Options | 5000 | $0.00 | 133,200.0000 | 0 | 3.90% | 0.00% |
| July 25, 2023 | Lexaria Bioscience Corp. | $LEXX | McKechnie William Edward | Director | A | Stock Options | 5000 | $0.00 | 93,200.0000 | 0 | 5.67% | 0.00% |